Back to Results
First PageMeta Content
ATryn / Anticoagulants / Genetic engineering / Goats / Medicine / Clinical research / Biopharmaceutical / Monoclonal antibodies / Antithrombin / Biotechnology / Biology / Pharmacology


Paris, 19 MayPress releaseGTC BIOTHERAPEUTICS Inc., a LFB group company, granted protection until 2027 on broad transgenic protein production patent, and is also granted new patent on recombinant antithrombin pro
Add to Reading List

Document Date: 2012-08-14 05:05:18


Open Document

File Size: 34,51 KB

Share Result on Facebook
UPDATE